[Chagas cardiomyopathy: prognosis in clinical and hemodynamic profile C]

Juliano Cardoso1, Milena Novaes, Marcelo Ochiai

  • 1InCor Hospital de Cotoxó, HCFMUSP, São Paulo, SP, Brasil. julianonc@cardiol.br

Insights

Patients with advanced heart failure (HF) and Chagas disease have a significantly worse prognosis. Chagas cardiomyopathy is an independent predictor of mortality in decompensated heart failure patients with profile C.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Context:

  • Patients with heart failure (HF) presenting with poor perfusion and congestion (clinical-hemodynamic profile C) exhibit the worst prognosis in decompensated HF.
  • Etiology of cardiomyopathy significantly impacts outcomes in advanced HF, yet remains understudied.

Purpose:

  • To evaluate the prognosis of patients admitted with clinical-hemodynamic profile C.
  • To determine the influence of cardiomyopathy etiology, specifically Chagas disease, on patient outcomes in advanced HF.

Summary:

  • A cohort study included 100 patients with advanced HF (LVEF < 45.0%, functional class IV, profile C), divided into chagasic (Ch) and non-chagasic (NCh) groups.
  • Chagasic patients were younger and had lower systolic blood pressure. Over 25 months, mortality was 66.7% for Ch versus 37.3% for NCh (p=0.019).
  • Chagas disease was identified as an independent predictor of poor prognosis (RR 2.75).

Impact:

  • This study highlights Chagas disease as a critical factor influencing mortality in advanced heart failure.
  • Findings underscore the need for considering Chagas etiology in risk stratification and management of HF patients.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...